Samsung Upgrades Galaxy Sleep Apnea Feature in U.S.
The updated feature on Galaxy Ring and Galaxy Watch 9 estimates breathing disruptions during sleep and provides risk information, not a clinical diagnosis.
Updated on Nov. 4, 2026 in Sleep Disorders

Live Poll
Would you trust a smart ring's sleep apnea screening over seeing a doctor?
Samsung has announced an upgraded Sleep Apnea feature for the Galaxy Ring and Galaxy Watch 9 in the United States. The upgraded version received a separate FDA clearance in July 2026, building on the original feature's FDA De Novo authorization from February 2024.
Why it matters
Samsung says it is the first company to offer FDA-cleared over-the-counter sleep apnea risk detection on a smart ring. The feature gives consumers a way to gauge possible sleep apnea risk using a wearable, though it is not a substitute for clinical diagnosis.
The feature requires two successful nights of sleep tracking, each with at least five hours of usable data, within a 10-day period. Availability in India is not yet confirmed, and support for the Galaxy Watch7 and Galaxy Watch8 is planned through future software updates.
The players
Samsung
Samsung is a South Korean electronics company whose Galaxy wearables and Samsung Health platform deliver the feature.
U.S. Food and Drug Administration (FDA)
The FDA is the federal agency that granted the original De Novo authorization and the separate 2026 clearance for the upgraded feature.
The details
The upgraded algorithm analyzes blood oxygen levels and movement during sleep to estimate breathing disruptions per hour through the Samsung Health Monitor app. The feature requires a compatible Samsung Galaxy smartphone running Android 12 or later and supports the Galaxy Ring and Galaxy Watch 9 running Wear OS 7.0 or later.
Timeline
February 2024: The original Sleep Apnea feature received FDA De Novo authorization.
July 2026: The upgraded version received a separate FDA clearance.
November 3, 2026: Samsung announced the upgraded feature and U.S. support.
Big Picture
The 2026 clearance extends the February 2024 De Novo authorization that first allowed FDA-recognized over-the-counter sleep apnea risk detection on Samsung wearables. Samsung's claim of being first to offer this on a smart ring positions the Galaxy Ring as the newest wearable entrant in that FDA-cleared category.
Readers who own a compatible Galaxy Ring or Galaxy Watch 9 can use the feature by completing two nights of tracking with at least five hours of sleep data each within 10 days. The result is a risk indication, so anyone with symptoms should still consult a clinician for diagnosis.
The takeaway
A risk estimate from a wearable can prompt a conversation with a doctor, but it does not replace a clinical sleep study. Users with loud snoring, daytime fatigue, or witnessed breathing pauses should seek professional evaluation.
Further reading
Explore more on Sleep Disorders for context on how sleep apnea is detected and managed.
Live Poll
Would you trust a smart ring's sleep apnea screening over seeing a doctor?










